{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:14:58Z","timestamp":1783329298629,"version":"3.54.6"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["\/OD P51 OD011106"],"award-info":[{"award-number":["\/OD P51 OD011106"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014520"],"award-info":[{"award-number":["P30CA014520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007856","name":"Baylor College of Medicine","doi-asserted-by":"publisher","award":["CHLA-136"],"award-info":[{"award-number":["CHLA-136"]}],"id":[{"id":"10.13039\/100007856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL142665"],"award-info":[{"award-number":["R01 HL142665"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["\/ NHLBI U01 HL134655"],"award-info":[{"award-number":["\/ NHLBI U01 HL134655"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201240","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:56:20Z","timestamp":1779260180000},"page":"201240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SIRP\u03b1 ablated iPSC-derived macrophages resist hypophagia and enhance mAb-dependent and CAR-mediated cytotoxicity of solid tumors"],"prefix":"10.1016","volume":"34","author":[{"given":"Portia R.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ehsanul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Maufort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H.","family":"Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divine M.","family":"Sedzro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian M.","family":"Capitini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-6927","authenticated-orcid":false,"given":"Igor I.","family":"Slukvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201240_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.semcancer.2008.03.004","article-title":"Macrophage polarization in tumour progression","volume":"18","author":"Sica","year":"2008","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.omton.2026.201240_bib2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","article-title":"The complex role of tumor-infiltrating macrophages","volume":"23","author":"Christofides","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.193.7.855","article-title":"Cd47-Signal Regulatory Protein \u03b1 (Sirp\u03b1) Regulates Fc\u03b3 and Complement Receptor\u2013Mediated Phagocytosis","volume":"193","author":"Oldenborg","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.omton.2026.201240_bib4","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.omton.2026.201240_bib5","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.immuni.2020.07.008","article-title":"CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis","volume":"53","author":"Morrissey","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.omton.2026.201240_bib6","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/cas.13663","article-title":"CD47-signal regulatory protein \u03b1 signaling system and its application to cancer immunotherapy","volume":"109","author":"Murata","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2026.201240_bib7","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.4049\/jimmunol.174.4.2004","article-title":"Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system","volume":"174","author":"Okazawa","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib8","first-page":"246","article-title":"Negatively regulating mechanism of Sirpalpha1 in hepatocellular carcinoma: an experimental study","volume":"5","author":"Qin","year":"2006","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.omton.2026.201240_bib9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jcp.22815","article-title":"Eat-me signals: Keys to molecular phagocyte biology and \u201cappetite\u201d control","volume":"227","author":"Li","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.omton.2026.201240_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13045-020-00930-1","article-title":"Role of CD47 in Hematological Malignancies","volume":"13","author":"Eladl","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12935-019-0957-0","article-title":"Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients","volume":"19","author":"Yuan","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.omton.2026.201240_bib12","first-page":"2901","article-title":"Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.omton.2026.201240_bib13","first-page":"1","article-title":"Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/cam4.478","article-title":"CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer","volume":"4","author":"Yoshida","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.omton.2026.201240_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00262-020-02806-2","article-title":"CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration","volume":"70","author":"Shi","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2026.201240_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000823","article-title":"Positive tumour CD47 expression is an independent prognostic factor for recurrence in resected non-small cell lung cancer","volume":"5","author":"Xu","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.omton.2026.201240_bib17","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/diagnostics12102291","article-title":"CD47 Expression Predicts Unfavorable Prognosis in Clear Cell Renal Cell Carcinoma after Curative Resection","volume":"12","author":"Park","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.omton.2026.201240_bib18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2010.07.044","article-title":"Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma","volume":"142","author":"Chao","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201240_bib19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1200\/JCO.18.02018","article-title":"First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers","volume":"37","author":"Sikic","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/2211-5463.13084","article-title":"Preclinical efficacy and toxicity studies of a highly specific chimeric anti-CD47 antibody","volume":"11","author":"Xu","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omton.2026.201240_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1158\/1078-0432.CCR-16-1700","article-title":"TTI-621 (SIRP\u03b1Fc): A CD47-Blocking Innate Immune Checkpoint Inhibitor with Broad Antitumor Activity and Minimal Erythrocyte Binding","volume":"23","author":"Petrova","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201240_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omton.2026.201240_bib23","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa1807315","article-title":"CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin\u2019s Lymphoma","volume":"379","author":"Advani","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2026.201240_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood-2007-06-098392","article-title":"Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide\/cGMP signaling","volume":"111","author":"Isenberg","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201240_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.matbio.2012.01.005","article-title":"The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47","volume":"31","author":"Roberts","year":"2012","journal-title":"Matrix Biol."},{"key":"10.1016\/j.omton.2026.201240_bib26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omton.2026.201240_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","article-title":"Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.stemcr.2022.12.012","article-title":"Generation of anti-GD2 CAR macrophages from human pluripotent stem cells for cancer immunotherapies","volume":"18","author":"Zhang","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omton.2026.201240_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.molcel.2008.05.026","article-title":"Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47","volume":"31","author":"Hatherley","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2026.201240_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib31","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1074\/jbc.M611511200","article-title":"The Structure of the Macrophage Signal Regulatory Protein \u03b1 (SIRP\u03b1) Inhibitory Receptor Reveals a Binding Face Reminiscent of That Used by T Cell Receptors","volume":"282","author":"Hatherley","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2026.201240_bib32","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1016\/j.csbj.2021.09.036","article-title":"Structural analysis and binding sites of inhibitors targeting the CD47\/SIRP\u03b1 interaction in anticancer therapy","volume":"19","author":"Huang","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.omton.2026.201240_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.stemcr.2014.09.014","article-title":"Tenascin C Promotes Hematoendothelial Development and T Lymphoid Commitment from Human Pluripotent Stem Cells in Chemically Defined Conditions","volume":"3","author":"Uenishi","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.omton.2026.201240_bib34","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1182\/blood.2023020597","article-title":"Macrophage heterogeneity in the single-cell era: facts and artifacts","volume":"142","author":"Hume","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201240_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109096","article-title":"MMP-9 secreted by tumor associated macrophages promoted gastric cancer metastasis through a PI3K\/AKT\/Snail pathway","volume":"117","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2026.201240_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13058-018-1076-x","article-title":"CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers","volume":"20","author":"Pelekanou","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.omton.2026.201240_bib37","first-page":"6040","article-title":"Tumor-associated macrophages induce invasion and poor prognosis in human gastric cancer in a cyclooxygenase-2\/MMP9-dependent manner","volume":"11","author":"Xu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.omton.2026.201240_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142979","article-title":"IL4I1 Is a Novel Regulator of M2 Macrophage Polarization That Can Inhibit T Cell Activation via L-Tryptophan and Arginine Depletion and IL-10 Production","volume":"10","author":"Yue","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omton.2026.201240_bib39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omton.2026.201240_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cellimm.2018.10.010","article-title":"Identification of M\u03a6 specific POTEE expression: Its role in mTORC2 activation via protein-protein interaction in TAMs","volume":"335","author":"Vekariya","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib41","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.2020005571","article-title":"Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance","volume":"136","author":"Pinney","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.omton.2026.201240_bib42","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fonc.2020.01000","article-title":"Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy","volume":"10","author":"Nazha","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib43","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.cub.2017.06.005","article-title":"SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors","volume":"27","author":"Alvey","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omton.2026.201240_bib44","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41467-021-23442-z","article-title":"Intratumoral SIRP\u03b1-deficient macrophages activate tumor antigen-specific cytotoxic T cells under radiotherapy","volume":"12","author":"Bian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201240_bib45","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41423-024-01220-3","article-title":"Silencing of SIRP\u03b1 enhances the antitumor efficacy of CAR-M in solid tumors","volume":"21","author":"Zhang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib46","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/s41467-025-59326-9","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2026.201240_bib47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/1878-0261.12628","article-title":"A SIRP\u03b1-Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer","volume":"14","author":"Huang","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib48","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/cancers14071847","article-title":"MMP9: A Tough Target for Targeted Therapy for Cancer","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2026.201240_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.778830","article-title":"Development of Exhausted Memory Monocytes and Underlying Mechanisms","volume":"12","author":"Pradhan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201240_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12957-023-03011-y","article-title":"Metastasis pattern and prognosis in children with neuroblastoma","volume":"21","author":"Liu","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.omton.2026.201240_bib51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","article-title":"Neuroblastoma: Molecular Pathogenesis and Therapy","volume":"66","author":"Louis","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omton.2026.201240_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.stem.2024.03.018","article-title":"Human anti-PSCA CAR macrophages possess potent antitumor activity against pancreatic cancer","volume":"31","author":"Shah","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omton.2026.201240_bib53","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.stem.2024.04.012","article-title":"Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity","volume":"31","author":"Shen","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.omton.2026.201240_bib54","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1182\/blood-2010-07-298331","article-title":"Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells","volume":"117","author":"Hu","year":"2011","journal-title":"Blood"}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926001165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:18:40Z","timestamp":1783325920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926001165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926001165"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201240","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SIRP\u03b1 ablated iPSC-derived macrophages resist hypophagia and enhance mAb-dependent and CAR-mediated cytotoxicity of solid tumors","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201240"}}